Slide 1: Regulation 30 intimation to stock exchanges
February 13, 2026 To, To, BSE Limited, Listing Department, 25, P. J. Towers, National Stock Exchange of India Ltd., Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai- 400051 Ref: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Intimation
Slide 2: Investor Presentation – February 2026
INTEGRATING SOLUTIONS ADDING VALUE Investor Presentation – February 2026 Camlin Fine Sciences Limited
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Camlin Fine Sciences Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
Slide 4: Q3 & 9MFY26 Performance Highlights
Q3 & 9MFY26 Performance Highlights
Slide 5: Q3 & 9MFY26 Operational Highlights
FY25 Q3 Operational & 9MFY26 Highlights Operational Highlights Revenue (Rs. In Mn) Operational EBITDA (Rs. In Mn) +9% 13,406 1,529 12,291 +6% 832 622 4,310 4,598 4,572 334 307 Q3 FY25 Q2 FY26 Q3 FY26 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 9M FY25 9M FY26 EBITDA Margin % PAT (Rs. In Mn) 267 16 14.40
Slide 6: Q3 & 9MFY26 Highlights
FY25 Q3 Operational & 9MFY26 Highlights Highlights • Revenue for the Q3FY26 stood at Rs. 4,572 mn, registering a growth of 6.1% YoY. • Pricing pressure on Straights impacted the profitability • Blends business maintains steady growth across key markets. • CFS acquired controlling stake in Vinpai on
Slide 7: Operational Revenue Breakup
Operational Revenue Operational RevenueBreakup Breakup From Continuing Operations Specialty Ingredients (Rs. In Mn) Specialty Ingredients (Rs. In Mn) Total Specialty Ingredients (Rs. In Mn) (Straights) (Value added blends) -13% +9% +2% 2,845 7,456 9,697 9,934 2,478 6,850 +11% +5% -11% 890 2,441 2,41
Slide 8: Regional Highlights
Regional Highlights Regional Highlights From Continuing Operations CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) +7% -4% +24% 6,544 3,883 3,736 495 6,139 399 +7% -6% +57% 2,440 2,189 1,360 1,285 182 2,051 1,201 129 116 Q3 FY25 Q2 FY26 Q3 FY26 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement From Continuing Operations Particulars (Rs. In Mn) Q3 FY26 Q3 FY25 Q2 FY26 9MFY26 9MFY25 Revenue from Operation 4,572.0 4,310.2 4,598.3 13,405.8 12,290.6 Raw material consumption 2,480.2 2,141.1 2,467.2 7,316.1 6,339.6 Employee Cost 637.6 479.2 602.9 1,836.3 1,42
Slide 10: Vinpai Acquisition
Innovation Vinpai at Work Acquisition • Incorporated in 2011 Key Rationale • Specializes in natural functional ingredients derived from algae, plants, minerals, and fibers, Portfolio Diversification: Vinpai specializes in algae- and offering alternatives to chemical additives plant-based functional
Slide 11: Company Overview
Company Overview
Slide 12: Company Overview
Company Overview FY25 Revenue Mix*# ₹ 16,319 mn 8 100+ 1,250+ Range of Diversified Base of Satisfied 23% Global Products offerings Customers Worldwide Manufacturing Facilities Preferred Partner High Quality & Wide For Customized Shelf-Life Solutions Range Vanillin Manufacturer 54% 7 Among Global 49,
Slide 13: Product Highlights
Product Highlights FY25 Sales%*# Key Products End User Industries Key Brands › TBHQ › Pet Food › Animal Feed Mills Straights 23% › BHA › Livestock Nutrition › Biodiesel › Ascorbyl palmitate (ASP) › Food & Beverages › Aquaculture & Fishmeal › Fish Meal › Rendering Specialty Ingredients › 200+ custom
Slide 14: Innovation at Work
Innovation at Innovation at Work Work Process Optimization Initiatives • Vanillin Production Optimization: Continuous improvement at Dahej plant, refining processes and setting a future – oriented strategic direction • Animal Nutrition: Dedicated to the continuous improvement and development of prod
Slide 15: Integration Chain
Integration Chain Phenol Hydroquinone Diphenols Catechol Manufactured In-house Performance Performance Specialty Ingredients Chemicals Aroma Ingredients Chemicals Ascorbyl Palmitate1 TBHQ MEHQ Guaiacol Guethol BHA Other derivatives of HQ Veratrole Vanillin Other derivatives of Blends Ethyl Vanillin
Slide 16: ESG
ESG ESG • Main goal by 2030 is to switch to renewable electricity for all manufacturing facilities. Currently, company is exploring different options to achieve this goal • Dedicated to sustainability and done few initiatives from reducing food waste to sourcing clean energy Environment • Constantly
Slide 17: Board Of Directors
Board Of Directors › Over three decades of experience in pharmaceuticals and › Managing Director of the MJ Group with over three decades of specialty chemical products including business planning, Ashish Dandekar Amol Shah experience covering human healthcare, F&F compounds, plant information system
Slide 18: Senior Management Team
Senior Management Team Ashish Dandekar › Over three decades of experience in pharmaceuticals and specialty chemical products including business planning, information systems, research & Chairman & Managing Director development, product development, and marketing › Holds a BA in Economics and Managem
Slide 19: Historical Financial Highlights
Historical Financial Highlights
Slide 20: Historical Financial Highlights
Historical Financial Highlights Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 15.3% 10.8% 12.7% 7.0% 9.3% Margin 16,816 16,131 16,928 654 604 2,131 1,574 398 14,121 1,819 978 530 494 11,871 1,528 14,539 16,665 1,836 2,081 -1,578 -2,075 1,591 -507 -1,049 263 -858 -1,581 FY21 FY22 FY23 FY24 F
Slide 21: Operational Revenue Break-Up
Operational Revenue Break-Up Specialty Ingredients (Rs. In Mn) Specialty Ingredients (Rs. In Mn) Total Specialty Ingredients (Rs. In Mn) (Straights) (Value added blends) 12,605 11,585 4,576 8,784 9,679 4,111 7,474 3,812 3,821 7,980 2,860 5,103 6,171 4,168 3,311 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY2
Slide 22: Regional Highlights
Regional Highlights CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) 8,865 4,822 5,062 4,883 7,894 7,733 4,395 6,855 3,762 6,000 3,533 3,198 2,735 679 525 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 CFS Brazil (Rs. In Mn) CFS North America (Rs. In Mn
Slide 23: Thank You !
Thank You ! Camlin Fine Sciences Ltd. CIN – L74100MH1993PLCO75361 Santosh Parab- CFO Email – santosh.parab@camlinfs.com santosh.parab@camlinfs.com www.camlinfs.com www.camlinfs.com http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Shrikant San